Clinical Trial Update: Identification and Evaluation of Patients at Risk of Developing Cardiotoxicity After Receiving Chemotherapy for Breast Cancer, Lymphoma or Leukemia

View source ↗

Summary

Clinical trial update from the Montreal Heart Institute describing efforts to identify and evaluate patients at risk of developing chemotherapy-induced cardioto…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Leukemia
• Lymphoma

Snippet

Sponsor: Montreal Heart Institute | Conditions: Breast Cancer, Lymphoma | Status: ACTIVE_NOT_RECRUITING